Evidence map›Paper›PMID 42354833›Full record

ReviewMicroorganisms2026

Clinical Features of Adult Patients with Isolated Pulmonary Valve Endocarditis: A Systematic Review.

Guillermo Cuervo, Supavit Chesdachai, Joya-Rita Hindy, Danielle Gerberi, Christopher V DeSimone, Abhishek J Deshmukh, José M Miró, Abdallah El Sabbagh, Daniel C DeSimone, Larry M Baddour

Abstract readReview
In one paragraph

Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guillermo CuervoInfectious Diseases Department, Hospital Clinic-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-7075-943X
Supavit ChesdachaiDepartment of Medicine, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN 55902, USA.ORCID 0000-0003-3507-6411
Joya-Rita HindyDepartment of Medicine, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN 55902, USA.
Danielle GerberiDepartment of Library Services, Mayo Clinic, Rochester, MN 55902, USA.ORCID 0000-0002-1522-3915
Christopher V DeSimoneDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55902, USA.
Abhishek J DeshmukhDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55902, USA.
José M MiróInfectious Diseases Department, Hospital Clinic-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-8057-7755
Abdallah El SabbaghDepartment of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.
Daniel C DeSimoneDepartment of Medicine, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN 55902, USA.
Larry M BaddourDepartment of Medicine, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN 55902, USA.ORCID 0000-0002-4473-7077

Funding

Biomedical Research Network Center of Infectious Diseases (CIBERINFEC) Mobility Grant (G. Cuervo)Hospital Clínic de Barcelona Mobility Grant (G. Cuervo)Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Personal 80:20 research grant (J.M. Miró)Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica Mobility Grant (G. Cuervo)
6 · The paper itself

Abstract

Isolated pulmonary valve endocarditis (PV-IE) is a rare condition. Its epidemiology, clinical profile, and management remain poorly characterized. A systematic review was conducted to provide a contemporary characterization (2020-2025) of adult cases with isolated PV-IE. Individuals with previous cardiac surgeries, cardiac implantable electronic devices (CIEDs), or long-term venous catheters were excluded. Of 1902 citations identified, 72 studies were selected with 79 eligible cases, mostly case reports. Patients were predominantly male (78.5%) with a median age of 43 years. Congenital heart disease (CHD) and injection drug use (IDU) were risk factors in 30.4% and 27.8% of cases, respectively, while 41.8% had neither (No-CHD/IDU group).

Indexed as

infective endocarditismicrobiologyoutcomespulmonic valve endocarditisright-sided infective endocarditisrisk factorssystematic review

Identifiers

PMID42354833
PMCPMC13303898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.